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The real joy in reading this book is that it truly combines the
wealth of knowledge that already exists on normal bone patho-
physiology and relates it relevantly to the biology of skeletal
metastases so setting the scene for the application of both tradi-
tional and newer pharmacological treatments.
A very impressive collection of authors contributes to the 25
chapters, which are coherently arranged in six sections. It is
written with the cancer physician in mind but the quality of the
text, particularly the pathophysiology section, would capture the
interest of any student at any level trying to comprehend the
complexities of both normal and abnormal bone physiology. This
book transforms the skeleton being viewed as a mystical if not
somewhat ‘inert’ structure to that of an active organ whose func-
tion is intricately linked with the haemopoietic system.
Perhaps it is the pace of scientific discovery in the last 15 years,
in particular as applied to the pathophysiology of bone, that has
heightened interest in this area. Although very detailed the chapter
on ‘Humoral hypercalcaemia of malignancy: the discovery of
PTHrp’ quite elegantly takes the reader from the first principle 
of an observation, through a series of logical well-thought-out
experiments using the technology as it became available, to the
discovery of what Gutman in 1936 described as ‘complex factors
as yet wholly obscure’.
The chapters generally follow on very nicely from one another,
gradually building and expanding on the knowledge laid down in
the preceding chapters. This has to be testament to the editorial
skills of the editor Jean-Jacques Body who has successfully
utilized the expert knowledge of the individual contributors
without having too much repetition and overlap between chapters.
Unfortunately, his task on the six chapters describing the pharma-
cology and increasing application of bisphosphonates in cancer
management was made more difficult because of their obvious
therapeutic success and potential. To date their use has revolu-
tionized and simplified the management of hypercalcaemia in
malignancy and been extended to not only the treatment of
painful osteolytic metastases but also preventing morbidity asso-
ciated with skeletal metastases. In addition, there is a body of
emerging data on their role in preventing the development of
skeletal and perhaps visceral metastases, not to mention their
increasing use in osteoporosis associated with cancer, which
makes them a very topical issue worthy of occupying a book on
their own.
The chapter on orthopaedic management of skeletal metastases
is particularly welcome as it is often relegated to a few lines in
most other oncology textbooks. It is well written with good illus-
tration and guidelines for management intervention.
I particularly enjoyed the overriding flavour of ‘food for
thought’ topics contained in this book for, e.g. role of tumour
markers in metastatic breast cancer involving the skeleton and use
of HRT in patients put at high risk of developing osteoporosis by
their cancer treatment. It is hard giving an up-to-the-minute
account of all relevant data in emerging fields in a text book, but
raising issues in this style and summarizing what is known so far
gets around this problem somewhat.
I found this an extremely informative and challenging read. It is
packed with so much information and data, particularly the early
chapters, that several reads are required to gain most benefit. It is
already a well-used text from my bookshelf.
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